🔥🐔 BizChicken 🐔🔥
Companies Similar to Neurogene Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Precigen, Inc.
gene and cellular therapies
Precigen, Inc. is focused on discovering and developing advanced gene and cellular therapies, disease-modifying therapeutics, and genetic engineering technologies for regenerative medicine and other applications.
About | Contact | Careers | Careers | Careers | About | About | Benefits | Careers | About | About | About | Careers | Careers | About
Symbol: PGEN
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Helen Sabzevari MPH, Ph.D.
Sector: Healthcare
Employees: 202
Address: 20374 Seneca Meadows Parkway, Germantown, MD 20876
Phone: 301 556 9900
Last updated: 2024-12-31
Neurocrine Biosciences, Inc.
INGREZZA
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for various conditions, focusing on innovative solutions for unmet medical needs.
Symbol: NBIX
Recent Price: $137.06
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Kyle W. Gano Ph.D.
Sector: Healthcare
Employees: 1700
Address: 12780 El Camino Real, San Diego, CA 92130
Phone: 858 617 7600
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Taysha Gene Therapies, Inc.
TSHA-120, TSHA-102, TSHA-121, TSHA-118, TSHA-105, TSHA-101
Taysha Gene Therapies, Inc. focuses on developing adeno-associated virus-based gene therapies for treating monogenic diseases of the central nervous system, with a pipeline including treatments for conditions such as giant axonal neuropathy, Rett syndrome, and GM2 gangliosidosis.
Symbol: TSHA
Recent Price: $1.73
Industry: Biotechnology
CEO: Mr. Sean P. Nolan
Sector: Healthcare
Employees: 52
Address: 3000 Pegasus Park Drive, Dallas, TX 75247
Phone: 214 612 0000
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
Generation Bio Co.
genetic medicines
Generation Bio Co. is a genetic medicines company developing therapies for rare and prevalent diseases, with a focus on the liver, retina, skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and is headquartered in Cambridge, Massachusetts.
Symbol: GBIO
Recent Price: $1.06
Industry: Biotechnology
CEO: Dr. Cameron Geoffrey McDonough M.D.
Sector: Healthcare
Employees: 174
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 655 7500
Last updated: 2024-12-31
Lexeo Therapeutics, Inc. Common Stock
LX2006, LX2020, LX2021, LX2022, LX1001, LX1020, LX1021, LX1004
Lexeo Therapeutics is a clinical-stage genetic medicine company developing innovative gene therapy candidates targeting hereditary and acquired diseases, including cardiomyopathies and neurological conditions.
Symbol: LXEO
Recent Price: $6.54
Industry: Biotechnology
CEO: Mr. R. Nolan Townsend
Sector: Healthcare
Employees: 69
Address: 345 Park Avenue South, New York, null 10010
Phone: 212-547-9879
Last updated: 2024-12-31
NeoGenomics, Inc.
Cancer-focused testing services
Neo Genomics, Inc. operates a network of cancer-focused testing laboratories offering various services such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, digital imaging, and molecular testing.
About | About | Leadership | Benefits | About | About | About | About | About | About | Contact | About | About | About
Symbol: NEO
Recent Price: $16.92
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher Michael Smith BSc
Sector: Healthcare
Employees: 2100
Address: 9490 NeoGenomics Way, Fort Myers, FL 33912
Phone: 239 768 0600
Leadership
- Chris Smith, Chief Executive Officer
- Jeff Sherman, Chief Financial Officer
- Warren Stone, Chief Commercial Officer
- Melody Harris, Chief Operations Officer & President, Informatics
- Ali Olivo, Executive Vice President, General Counsel & Business Development
- Hutan Hashemi, JD, Chief Compliance Officer
- Nathan Montgomery, MD, PhD, Vice President, Medical Services
- Gary Passman, Chief Culture Officer
- Kareem Saad, Head of Strategy and Transformation
- Lynn A. Tetrault, Chair of the Board
- Bruce K. Crowther, Board Member
- Elizabeth Floegel, Board Member
- Neil Gunn, Board Member
- Alison L. Hannah, MD, Board Member
- Stephen Kanovsky, Board Member
- Michael A. Kelly, Board Member
- David Perez, Board Member
- Tony Zook, Board Member
- Derek Lyle, MD, Chief Medical Officer
- Vladislav Chizhevsky, MD SSBBP, Medical Director, Aliso Viejo, California
- J. Christopher Mixon, MD, Medical Director, Nashville, Tennessee
- Anahit Nowrouzi, MD, Medical Director, Fort Myers, Florida
- Tricia Peters, MD, Medical Director, Houston, Texas Molecular Pathologist, Pharma Services
- Yin Xu, MD PhD FCAP, Medical Director, Carlsbad and Atlanta; Global Medical Director, Pharma Services
- Renuka Agrawal, MD, Senior Hematopathologist
- Todd S. Barry, MD PhD, Senior Hematopathologist
- Bora Baysal, MD, PhD, Senior Hematopathologist
- Saskia Boisot, MD, Senior Hematopathologist
- Wayne W. Chen, MD PhD, Director of Hematopathology Services
- Rachel Flamholz, MD, Senior Hematopathologist
- Michael Hayes, MD, Senior Hematopathologist / Surgical Pathologist
- Anselm Hii, MD, Director of Hematopathology Services
- Thanh Ho, MD, Senior Hematopathologist
- Kim Janatpour, MD MA, Senior Hematopathologist
- Shiping Jiang, MD PhD, Senior Hematopathologist and Surgical Pathologist
- Sameer S. Khatri, MD, Hematopathologist
- Madeleine Kraus, MD, Senior Hematopathologist
- Brian Kwok, MD FCAP, Corporate Director of Hematopathology
- Keming Lin, MD MS FCAP, Senior Hematopathologist
- Robert Lin, MD, Senior Hematopathologist
- Russell L. Maiese, M.D., Senior Hematopathologist
- Mojdeh Naghashpour, MD PhD, Senior Hematopathologist
- Viera Nelson, MD, Senior Hematopathologist
- Dennis P. O’Malley, MD, Senior Hematopathologist
- Anthony Padula, MD, Senior Hematopathologist
- Munir Shahjahan, MD MPH, Senior Hematopathologist
- Jesalyn J. Taylor, MD, Senior Hematopathologist
- Jian-Feng Wang, MD PhD, Senior Hematopathologist
- Zhao Wu, MD PhD FCAP, Senior Hematopathologist
- Aine Yung, MD FCAP, Senior Hematopathologist
- Sadiq Zaman, MD, Senior Hematopathologist
- Guohua Zhao, MD PhD, Senior Hematopathologist
- Mitual Amin, MD, Senior Surgical Pathologist
- Jerry Chu, MD PhD, Senior Surgical Pathologist
- Ted Farzaneh, MD, Senior Surgical Pathologist
- Thomas K. Lee, MD PhD, Director of Surgical Pathology Services
- Takako Mitsuhashi, MD PhD, Senior Dermatopathologist and Surgical Pathologist
- Robert Schwartz, MD, Senior Surgical Pathologist
- Yae K (Kay) Suh, MD, Senior Surgical Pathologist
- Matthew Geller, DO, Molecular Pathologist
- Hao Ho, MD, Molecular Pathologist
- Jennifer Hummel, MD, Senior Molecular Pathologist
- Armen Kaysan, MD, Molecular Pathologist
- Kalpana S. Reddy, MD, Hematopathologist and Molecular Pathologist
- Saed Sadeghi, MD, Molecular Pathologist
- Ying Wang, MD PhD, Molecular Pathologist
- Shehla Arain, MD, Senior Surgical Pathologist, Pharma Services
- Chunghun George Chang, md, Surgical and Hemepath Pathologist, Pharma Services
- Indu Gupta, MD, Surgical Pathologist, Pharma Services
- Valerie Harris-Morris, MD, Hemepath Pathologist, Pharma Services
- Albert Ho, Director of Pharma Pathology Services
- Henry Tsai, MD PhD, Surgical Pathologist, Pharma Services
- Sujata Chakraborty, PhD FACMGG, Director, Cytogenetics and Molecular Genetics
- Li Cheng, PhD FACMG, Associate Director of Cytogenetics
- Liang Dong, MD PhD, Director of Cytogenetic Services
- Mohamed M. Elnaggar, MD MS FACMG, Director of Cytogenetic Services
- Michele Hibbard/Kempik, PhD FACMG, Director of Genetics
- Fernando J. López-Díaz, PhD, Director of Clinical Science, Research and Development
- John R. McGill, PhD FACMGG, Medical Director of Cytogenetics and Technical Director of FISH
- Mike Nahorski, PhD, Director, Clinical and Scientific Alliances
- Farzad Nooraie, MD, Director of Cytogenetic Services
- Róisín Puentes, PharmD, PhD, Medical Science Liaison, Medical Affairs
- Siby Sebastian, Ph.D, FACMGG, DABCC, Lab Director, Research Triangle Park (RTP), North Carolina
- Guoxian Sun, MD DABMG FACMG, Director of Cytogenetic Services
- Jadwiga Szymanska, PhD FACMG, Director of Cytogenetics
- Maya Thangavelu, PhD, Medical Director of Cytogenetics and Technical Director of FISH
- Qinqin Zha, PhD, Principal Scientist, Associate Director, Scientific Affairs
- John N. Allan, MD, Scientific Advisory Board Member
- Rafael Bejar, MD, PhD, Scientific Advisory Board Member
- James R. Berenson, MD, Scientific Advisory Board Member
- Riccardo Dalla-Favera, PhD, Scientific Advisory Board Member
- James Downing, MD, Scientific Advisory Board Member
- Bernard A Fox, PhD, Scientific Advisory Board Member
- Gregory Hess, MD, Scientific Advisory Board Member
- Hatim Husain, MD, Scientific Advisory Board Member
- Tibor Kovacsovics, MD, Scientific Advisory Board Member
- Razelle Kurzrock, MD, Scientific Advisory Board Member
- Gail J. Roboz, MD, Scientific Advisory Board Member
- Steven T. Rosen, MD, FACP, FASCO, FAIMBE, Scientific Advisory Board Member
- Mark A. Rubin, MD, Scientific Advisory Board Member
Last updated: 2024-12-31
Neurogene Inc.
NGN-401, NGN-101
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases, focusing on gene therapy products like NGN-401 for Rett syndrome and NGN-101 for neuronal ceroid lipofuscinosis subtype 5 batten disease.
About | Contact | Contact | Careers | Jobs | Jobs | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About
Symbol: NGNE
Recent Price: $22.28
Industry: Biotechnology
CEO: Dr. Rachel L. McMinn Ph.D.
Sector: Healthcare
Employees: 91
Address: 535 W 24th Street, New York, NY 10011
Phone: (877) 237-5020
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
PepGen Inc.
PGN-EDO51
Pep Gen Inc. is a clinical-stage biotechnology company developing oligonucleotide therapeutics for neuromuscular and neurologic diseases. Its lead product, PGN-EDO51, is in Phase I trials for Duchenne muscular dystrophy.
Symbol: PEPG
Recent Price: $3.83
Industry: Biotechnology
CEO: Dr. James G. McArthur Ph.D.
Sector: Healthcare
Employees: 72
Address: 245 Main Street, Cambridge, MA 02142
Phone: 781-797-0979
Last updated: 2024-12-31
Protagenic Therapeutics, Inc.
PT00114
Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing therapeutics for stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, aims to regulate stress response and restore healthy brain function.
Symbol: PTIX
Recent Price: $0.54
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 1
Address: 149 Fifth Avenue, New York, NY 10010
Phone: 212 994 8200
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
Titan Pharmaceuticals, Inc.
Pro Neura
Titan Pharmaceuticals, Inc. is a pharmaceutical company developing therapeutics for chronic diseases utilizing the Pro Neura drug delivery platform. Its products include the Probuphine implant for opioid use disorder treatment, among other programs for chronic pruritus, opioid relapse prevention, HIV prevention, and contraception.
About | About | Leadership | Directors | About | Contact | Directors | Directors | Directors | Careers | About
Symbol: TTNP
Recent Price: $3.40
Industry: Biotechnology
CEO: Jennifer Kiernan
Sector: Healthcare
Employees: 4
Address: 400 Oyster Point Boulevard, South San Francisco, CA 94080-1958
Phone: 650 244 4990
Leadership
- Dato’ Seow Gim Shen, Chief Executive Officer and Chairman of the Board of Directors
- Avraham Ben-Tzvi, Founder
- Brynner Chiam, Vice President of Finance and Tax
- Firdauz Edmin Bin Mokhtar, Chief Executive Officer
- Francisco Osvaldo Flores García, Managing Partner
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Vigil Neuroscience, Inc.
VGL101
Vigil Neuroscience, Inc. is a microglia-focused company developing disease-modifying therapeutics for neurodegenerative diseases. Their lead product candidate, VGL101, is a monoclonal antibody in Phase I trial for various neurodegenerative conditions.
Symbol: VIGL
Recent Price: $1.53
Industry: Biotechnology
CEO: Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
Sector: Healthcare
Employees: 64
Address: 1 Broadway, Cambridge, MA 02142
Phone: 857 254 4445
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31